Can we prevent or treat renal dysfunction in acute heart failure?

Lazzarini, Valentina; Bettari, Luca; Bugatti, Silvia; Carubelli, Valentina; Lombardi, Carlo; Metra, Marco; Dei Cas, Livio

Lazzarini, Valentina; Bettari, Luca; Bugatti, Silvia; Carubelli, Valentina; Lombardi, Carlo; Metra, Marco; Dei Cas, Livio.

Affiliation

Lazzarini V; Department of Experimental and Applied Medicine, Section of Cardiovascular Diseases, University of Brescia, Piazzale Spedali Civili 1, 25123 Brescia, Italy. valentina.lazzarini@gmail.com

Heart Fail Rev ; 17(2): 291-303, 2012 Mar.

Article in En | MEDLINE | ID: mdl-21556945

Subject(s)

Heart Failure/drug therapy; Kidney Diseases/etiology; Kidney/physiopathology; Mineralocorticoid Receptor Antagonists/therapeutic use; Vasodilator Agents/therapeutic use; Acute Disease; Adenosine/antagonists & inhibitors; Biomarkers/metabolism; Cardiotonic Agents/therapeutic use; Diuretics/therapeutic use; Dopamine/therapeutic use; Heart Failure/complications; Heart Failure/physiopathology; Humans; Kidney Diseases/drug therapy; Prognosis; Vasopressins/antagonists & inhibitors

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vasodilator Agents / Mineralocorticoid Receptor Antagonists / Heart Failure / Kidney / Kidney Diseases Type of study: Prognostic_studies Limits: Humans Language: En Journal: Heart Fail Rev Journal subject: CARDIOLOGIA Year: 2012 Type: Article Affiliation country: Italy

Fulltext

XML

PubMed Links

Search on Google